SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
kecy
Lv2
180 积分
2024-02-04 加入
最近求助
最近应助
互助留言
Cancer incidence and mortality in China, 2022
10天前
已完结
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
14天前
已完结
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
17天前
已完结
Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer
24天前
已完结
The drug lag issue: a 20-year review of China
1个月前
已完结
Bispecific antibodies
2个月前
已完结
Bispecific antibodies: a mechanistic review of the pipeline
2个月前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
2个月前
已完结
The clinical development of antibody–drug conjugates — lessons from leukaemia
2个月前
已完结
Obesogenic diet disrupts tissue-specific mitochondrial gene signatures in the artery and capillary endothelium
2个月前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论